[
    [
        {
            "time": "",
            "original_text": "“黄金赛道”下的医美机构众生相：高毛利低净利，90%亏损，上游壁垒高，终端风险大 亏损",
            "features": {
                "keywords": [
                    "医美",
                    "高毛利",
                    "低净利",
                    "90%亏损",
                    "上游壁垒",
                    "终端风险"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "美容"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "“黄金赛道”下的医美机构众生相：高毛利低净利，90%亏损，上游壁垒高，终端风险大 亏损",
                "Correlation": 7,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "爱博医疗拟进军医美 合资方现原华熙生物CEO金雪坤身影",
            "features": {
                "keywords": [
                    "爱博医疗",
                    "医美",
                    "华熙生物",
                    "CEO",
                    "金雪坤"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "美容"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "爱博医疗拟进军医美 合资方现原华熙生物CEO金雪坤身影",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "华熙生物“抢跑”食用透明质酸，何时能成国货“资生堂”？",
            "features": {
                "keywords": [
                    "华熙生物",
                    "透明质酸",
                    "食用",
                    "资生堂"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "食品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华熙生物“抢跑”食用透明质酸，何时能成国货“资生堂”？",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]